Pène Frédéric, Hissem Tarik, Bérezné Alice, Allanore Yannick, Geri Guillaume, Charpentier Julien, Avouac Jérôme, Guillevin Loïc, Cariou Alain, Chiche Jean-Daniel, Mira Jean-Paul, Mouthon Luc
From the Réanimation médicale, and Médecine Interne, and Rhumatologie A, Centre National de Référence des maladies systémiques et autoimmunes rares, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP); Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.F. Pène, MD, PhD, Réanimation médicale, Hôpital Cochin, AP-HP, and Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité; T. Hissem, MD, Réanimation médicale, Hôpital Cochin, AP-HP; A. Bérezné, MD, Médecine Interne, and Centre National de Référence des maladies systémiques et autoimmunes rares, Hôpital Cochin, AP-HP; Y. Allanore, MD, PhD, Rhumatologie A, Hôpital Cochin, AP-HP, and Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité; G. Geri, MD, Réanimation médicale, Hôpital Cochin, AP-HP, and Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité; J. Charpentier, MD, Réanimation médicale, Hôpital Cochin, AP-HP; J. Avouac, MD, PhD, Rhumatologie A, Hôpital Cochin, AP-HP, and Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité; L. Guillevin, MD, Médecine Interne, and Centre National de Référence des maladies systémiques et autoimmunes rares, Hôpital Cochin, AP-HP, and Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité; A. Cariou, MD, PhD; J.D. Chiche, MD, PhD; J.P. Mira, MD, PhD, Réanimation médicale, Hôpital Cochin, AP-HP, and Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité; L. Mouthon, MD, PhD, Médecine Interne, and Centre National de Référence des maladies systémiques et autoimmunes rares, Hôpital Cochin, AP-HP, and Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité.
J Rheumatol. 2015 Aug;42(8):1406-12. doi: 10.3899/jrheum.141617. Epub 2015 Jul 1.
Patients with systemic sclerosis (SSc) are prone to disease-specific or treatment-related life-threatening complications that may warrant intensive care unit (ICU) admission. We assessed the characteristics and current outcome of patients with SSc admitted to the ICU.
We performed a single-center retrospective study over 6 years (November 2006-December 2012). All patients with SSc admitted to the ICU were enrolled. Short-term (in-ICU and in-hospital) and longterm (6-mo and 1-yr) mortality rates were studied, and the prognostic factors were analyzed.
Forty-one patients with a median age of 50 years [interquartile range (IQR) 40-65] were included. Twenty-nine patients (72.5%) displayed diffuse cutaneous SSc. The time from diagnosis to ICU admission was 78 months (IQR 34-128). Twenty-eight patients (71.7%) previously had pulmonary fibrosis, and 12 (31.5%) had pulmonary hypertension. The main reason for ICU admission was acute respiratory failure in 27 patients (65.8%). Noninvasive ventilation was first attempted in 13 patients (31.7%) and was successful in 8 of them, whereas others required endotracheal intubation within 24 h. Altogether, 13 patients (31.7%) required endotracheal intubation and mechanical ventilation. The overall in-ICU, in-hospital, 6-month, and 1-year mortality rates were 31.8%, 39.0%, 46.4%, and 61.0%, respectively. Invasive mechanical ventilation was the worst prognostic factor, associated with an in-hospital mortality rate of 84.6%.
This study provides reliable prognostic data in patients with SSc who required ICU admission. The devastating outcome of invasive mechanical ventilation in patients with SSc requires a reappraisal of indications for ICU admission and early identification of patients likely to benefit from noninvasive ventilation.
系统性硬化症(SSc)患者易发生特定疾病或与治疗相关的危及生命的并发症,可能需要入住重症监护病房(ICU)。我们评估了入住ICU的SSc患者的特征和当前结局。
我们进行了一项为期6年(2006年11月至2012年12月)的单中心回顾性研究。纳入所有入住ICU的SSc患者。研究短期(在ICU期间和住院期间)和长期(6个月和1年)死亡率,并分析预后因素。
纳入41例患者,中位年龄为50岁[四分位间距(IQR)40 - 65]。29例患者(72.5%)表现为弥漫性皮肤型SSc。从诊断到入住ICU的时间为78个月(IQR 34 - 128)。28例患者(71.7%)既往有肺纤维化,12例(31.5%)有肺动脉高压。入住ICU的主要原因是27例患者(65.8%)发生急性呼吸衰竭。13例患者(31.7%)首先尝试无创通气,其中8例成功,而其他患者在24小时内需要气管插管。共有13例患者(31.7%)需要气管插管和机械通气。总体ICU内、住院期间、6个月和1年死亡率分别为31.8%、39.0%、46.4%和61.0%。有创机械通气是最不利的预后因素,住院死亡率为84.6%。
本研究为需要入住ICU的SSc患者提供了可靠的预后数据。SSc患者有创机械通气的灾难性结局需要重新评估入住ICU的指征,并早期识别可能从无创通气中获益的患者。